Clinical Trials Browser

Phase 2 × Anatomic Stage I Breast Cancer AJCC v8 × Cyclophosphamide × Clear all

NCT06042569 2025-10-09

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

Phase 2 Recruiting

Anatomic Stage I Breast Cancer AJCC v8